Bone complications in children with Gaucher disease

Area of Science:

• Pediatric Endocrinology
• Rare Genetic Disorders
• Skeletal Biology

Background:

• Gaucher disease can cause irreversible skeletal complications in children.
• Analysis of skeletal data requires consideration of pubertal growth and bone marrow changes.
• Enzyme replacement therapy (ERT) is a potential treatment for Gaucher disease.

Purpose of the Study:

• To evaluate the impact of ERT on bone mineral density (BMD) and skeletal growth in pediatric patients with Gaucher disease.
• To assess the long-term efficacy of ERT in preventing skeletal complications.

Main Methods:

• Retrospective analysis of skeletal data from pediatric patients receiving ERT.
• Studies conducted at multiple treatment centers (Italy, USA, Germany).
• Follow-up periods ranging from 2 to 9 years.

Main Results:

• ERT significantly increased mean lumbar BMD Z scores in pediatric patients (p=0.003).
• Skeletal growth rates improved in patients with growth delays.
• Significant increases in lumbar BMD were observed in 6 out of 11 patients after 2 years of ERT, particularly those with lower initial BMD.
• Children with type 1 Gaucher disease showed increased distal ulna BMD after 18-24 months of ERT.

Conclusions:

• ERT demonstrates potential to improve BMD and growth rates in pediatric Gaucher disease patients.
• ERT may prevent serious skeletal complications, including fractures and vertebral compression, in the long term.